Literature DB >> 17406148

Ewing's sarcoma metastasis to the gastric wall in a 72-year-old patient.

Laura Borodyansky Dodis1, Michael William Bennett, David L Carr-Locke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17406148      PMCID： PMC1781288     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  10 in total

1.  Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.

Authors:  C M Hattinger; S Rumpler; S Strehl; I M Ambros; A Zoubek; U Pötschger; H Gadner; P F Ambros
Journal:  Genes Chromosomes Cancer       Date:  1999-03       Impact factor: 5.006

2.  Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.

Authors:  M E Nesbit; E A Gehan; E O Burgert; T J Vietti; A Cangir; M Tefft; R Evans; P Thomas; F B Askin; J M Kissane
Journal:  J Clin Oncol       Date:  1990-10       Impact factor: 44.544

3.  Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies.

Authors:  A Cangir; T J Vietti; E A Gehan; E O Burgert; P Thomas; M Tefft; M E Nesbit; J Kissane; D Pritchard
Journal:  Cancer       Date:  1990-09-01       Impact factor: 6.860

4.  Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial.

Authors:  H Jürgens; U Exner; H Gadner; D Harms; J Michaelis; R Sauer; J Treuner; T Voûte; W Winkelmann; K Winkler
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

5.  Prognostic impact of P53 status in Ewing sarcoma.

Authors:  E de Alava; C R Antonescu; A Panizo; D Leung; P A Meyers; A G Huvos; F J Pardo-Mindán; J H Healey; M Ladanyi
Journal:  Cancer       Date:  2000-08-15       Impact factor: 6.860

6.  Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma.

Authors:  B Widhe; T Widhe
Journal:  J Bone Joint Surg Am       Date:  2000-05       Impact factor: 5.284

7.  Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience.

Authors:  S Parasuraman; J Langston; B N Rao; C A Poquette; J J Jenkins; T Merchant; A Cain; C B Pratt; A S Pappo
Journal:  J Pediatr Hematol Oncol       Date:  1999 Sep-Oct       Impact factor: 1.289

8.  Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.

Authors:  S J Cotterill; S Ahrens; M Paulussen; H F Jürgens; P A Voûte; H Gadner; A W Craft
Journal:  J Clin Oncol       Date:  2000-09       Impact factor: 44.544

9.  Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.

Authors:  S Ferrari; M Mercuri; P Rosito; A Mancini; E Barbieri; A Longhi; S Rimondini; M Cesari; P Ruggieri; M Di Liddo; G Bacci
Journal:  J Chemother       Date:  1998-12       Impact factor: 1.714

10.  Extraosseous Ewing's sarcoma. A study of 42 cases.

Authors:  N P Rud; H M Reiman; D J Pritchard; F J Frassica; W A Smithson
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860
  10 in total
  1 in total

1.  PNET/Ewing's sarcoma of the rectum: a case report and review of the literature.

Authors:  Omar M Aboumarzouk; Robert Coleman; John R Goepel; Andrew J Shorthouse
Journal:  BMJ Case Rep       Date:  2009-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.